Cardiac Surgery

Cardiothoracic surgery includes coronary artery bypass surgery (CABG), heart valve repair or replacement, left ventricular assist device (LVAD) placement, heart transplant, assisting in minimally invasive transcatheter valve structural heart procedures such as TAVR, left atrial appendage (LAA) occlusion, septal myectomy, surgical ablation for arrhythmias, and reconstruction of the heart in congenial heart disease cases. 

BiVACOR Total Artificial Heart

FDA approves early feasibility study for total artificial heart technology

The device is intended to be a bridge for heart failure patients waiting to receive a full heart transplant.

Surgeons Operating On Patient

‘We should halt this practice’: Common hormone treatment for donated hearts may be harmful

"This practice has been adopted by multiple organ-procurement organizations and is used on thousands of organ donors each year, without ever having been rigorously studied," one researcher said. 

money business cash flow dollar

Robotic-assisted CABG reduces healthcare costs, primarily thanks to shorter hospital stays

The technology may not be cheap, but new research published in The American Journal of Cardiology suggests the investment is well worth it. 

Cardiawave Valvosoft non-invasive ultrasound therapy

Cardiawave’s non-invasive ultrasound therapy impresses cardiologists early on—could it be an alternative to SAVR, TAVR?

While TAVR and SAVR are reliable treatments for calcific aortic stenosis, some patients are not considered for those procedures due to severe comorbidities or a limited life expectancy. This is where the investigational Valvosoft device from Cardiawave enters the equation.

Medtronic Penditure Left Atrial Appendage (LAA) Exclusion System

Medtronic debuts new FDA-cleared LAA exclusion device

Medtronic acquired the technology behind the new device back in August.

older patient with a doctor at their house

Ross procedure still linked to ‘excellent’ outcomes as patients enter third decade after surgery

Researchers focused on more than 100 patients who underwent the Ross procedure from 1994 to 2001, sharing their findings in JAMA Cardiology.

Thumbnail

Surgeons warn it is too early to recommend a TAVR-first strategy for low-risk patients

The Society of Thoracic Surgeons and European Association for Cardio-Thoracic Surgery say more information is still required before any conclusions can be made about the long-term benefits of TAVR in low-risk patients.

Kendra Grubb discusses TAVR vs SAVR and the most recent data to explain choices with patients.

TAVR or SAVR? Where things stand now, from a surgeon's perspective

Kendra Grubb, MD, one of the country's leading experts on cardiac surgery, discussed what she tells her patients when they ask if TAVR is better than SAVR for treating severe aortic stenosis. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup